Literature DB >> 7815420

Apolipoprotein CII-Padova (Tyr37-->stop) as a cause of chylomicronaemia in an Italian kindred from Siculiana.

S Tuzgöl1, S M Bijvoet, T Bruin, J J Kastelein, M R Hayden.   

Abstract

In this paper we report on the molecular defect underlying apolipoprotein CII (apoCII) deficiency in an Italian kindred. ApoCII serves as cofactor for lipoprotein lipase (LPL) in triglyceride hydrolysis of chylomicrons and very low density lipoproteins. Homozygous apoCII deficiency manifests with type I hyperlipoproteinaemia and is a rare disorder of lipoprotein metabolism. Until now, only 10 kindreds with apoCII deficiency have been published and all underlying mutations were unique. The proband was the offspring of a consanguineous mating. Sequencing of cloned DNA from the proband presented in this report showed homozygosity for a C-->A substitution at position 3002 in the apoCII gene, resulting in the introduction of a premature stop codon at residue 37 of the mature apoCII protein. Therefore, a truncated apoCII is synthesised, lacking the part of the apolipoprotein that activates LPL. This mutation has previously been described in another Italian family and is known as apoCIIPadova. We propose that apoCIIPadova is a frequent cause of apoCII deficiency in persons of Italian descent.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7815420      PMCID: PMC1050024          DOI: 10.1136/jmg.31.8.622

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

Review 1.  Structure and functional properties of lipoprotein lipase.

Authors:  C S Wang; J Hartsuck; W J McConathy
Journal:  Biochim Biophys Acta       Date:  1992-01-03

2.  Interaction between variant apolipoproteins C-II and E that affects plasma lipoprotein concentrations.

Authors:  R A Hegele; W C Breckenridge; D W Cox; G F Maguire; J A Little; P W Connelly
Journal:  Arterioscler Thromb       Date:  1991 Sep-Oct

3.  Identification of the mutation responsible for a case of plasmatic apolipoprotein CII deficiency (Apo CII-Bari).

Authors:  C Crecchio; A Capurso; G Pepe
Journal:  Biochem Biophys Res Commun       Date:  1990-05-16       Impact factor: 3.575

4.  Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man.

Authors:  R J Havel; J P Kane; M L Kashyap
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

5.  Isolation and characterization of apoLp-Gln-II (apoA-II), a plasma high density apolipoprotein containing two identical polypeptide chains.

Authors:  S E Lux; K M John; H B Brewer
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

6.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

7.  A specific apoprotein activator for lipoprotein lipase.

Authors:  J C LaRosa; R I Levy; P Herbert; S E Lux; D S Fredrickson
Journal:  Biochem Biophys Res Commun       Date:  1970-10-09       Impact factor: 3.575

Review 8.  The genetics and molecular biology of apolipoprotein CII.

Authors:  M R Hayden; C Vergani; S E Humphries; L Kirby; R Shukin; R McLeod
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

9.  A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries.

Authors:  M V Monsalve; H Henderson; G Roederer; P Julien; S Deeb; J J Kastelein; L Peritz; R Devlin; T Bruin; M R Murthy
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

10.  Apolipoprotein C-II deficiency: identification of a structural variant ApoC-II Padova.

Authors:  S S Fojo; G Baggio; C Gabelli; K Higuchi; M Bojanovski; R E Gregg; H B Brewer
Journal:  Biochem Biophys Res Commun       Date:  1988-07-15       Impact factor: 3.575

View more
  1 in total

Review 1.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.